IDEXX Laboratories, Inc.
IDXX
$491.70
$1.720.35%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 5.56% | 6.46% | 7.16% | 7.70% | 8.57% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.56% | 6.46% | 7.16% | 7.70% | 8.57% |
| Cost of Revenue | 2.55% | 3.24% | 4.95% | 6.52% | 7.41% |
| Gross Profit | 7.55% | 8.63% | 8.64% | 8.49% | 9.35% |
| SG&A Expenses | -1.23% | 0.65% | -0.25% | 6.48% | 7.81% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.06% | 3.21% | 4.00% | 7.05% | 4.36% |
| Operating Income | 13.73% | 14.06% | 14.52% | 9.25% | 19.86% |
| Income Before Tax | 3.26% | 4.59% | 5.64% | 6.10% | 22.88% |
| Income Tax Expenses | 3.18% | 2.70% | 7.02% | 3.29% | 18.94% |
| Earnings from Continuing Operations | 3.28% | 5.07% | 5.29% | 6.85% | 23.94% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 3.28% | 5.07% | 5.29% | 6.85% | 23.94% |
| EBIT | 13.73% | 14.06% | 14.52% | 9.25% | 19.86% |
| EBITDA | 13.86% | 13.96% | 14.15% | 8.98% | 17.96% |
| EPS Basic | 4.66% | 5.82% | 5.62% | 6.95% | 24.13% |
| Normalized Basic EPS | 16.01% | 17.00% | 17.95% | 12.39% | 23.08% |
| EPS Diluted | 4.84% | 6.06% | 5.60% | 6.99% | 24.03% |
| Normalized Diluted EPS | 16.24% | 17.18% | 18.11% | 12.48% | 23.13% |
| Average Basic Shares Outstanding | -1.28% | -0.72% | -0.30% | -0.10% | -0.22% |
| Average Diluted Shares Outstanding | -1.48% | -0.87% | -0.42% | -0.18% | -0.26% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |